{"id":10927,"date":"2024-12-26T03:34:54","date_gmt":"2024-12-26T03:34:54","guid":{"rendered":"https:\/\/www.tcm-vet.com\/?p=10927"},"modified":"2024-12-26T03:37:28","modified_gmt":"2024-12-26T03:37:28","slug":"dalak-lenfomasi-belirtilerinin-anlasilmasi-tanisi-ve-tedavi-secenekleri","status":"publish","type":"post","link":"https:\/\/www.tcm-vet.com\/tr\/understanding-splenic-lymphoma-symptoms-diagnosis-and-treatment-options\/","title":{"rendered":"Dalak Lenfomas\u0131n\u0131 Anlamak: Belirtiler, Tan\u0131 ve Tedavi Se\u00e7enekleri"},"content":{"rendered":"

Dalak lenfomas\u0131, v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sisteminde \u00f6nemli bir organ olan dalak \u00fczerinde etkili olan nadir ve genellikle zorlu bir hastal\u0131kt\u0131r. Lenfoma genellikle Hodgkin ve Hodgkin d\u0131\u015f\u0131 t\u00fcrler olarak kategorize edilse de, dalak lenfomas\u0131 genellikle ikincisine girer. Bu durum, dalakta anormal lenfositlerin (bir t\u00fcr beyaz kan h\u00fccresi) kontrols\u00fcz b\u00fcy\u00fcmesi ile karakterizedir. Bu makale, dalak lenfomas\u0131n\u0131n patofizyolojisi, belirtileri, tan\u0131 yakla\u015f\u0131mlar\u0131 ve tedavi se\u00e7eneklerine dalmaktad\u0131r.<\/p>\n\n\n\n

Dalak Lenfomas\u0131 Nedir?<\/h3>\n\n\n\n

Dalak lenfomas\u0131, esas olarak dalak \u00fczerinde etkili olan bir Hodgkin d\u0131\u015f\u0131 lenfoma (NHL) t\u00fcr\u00fcd\u00fcr, ancak di\u011fer lenfatik dokulara da yay\u0131labilir. NHL, lenf d\u00fc\u011f\u00fcmleri, dalak, kemik ili\u011fi ve di\u011fer organlar gibi lenfatik dokularda ortaya \u00e7\u0131kan \u00e7e\u015fitli kan kanserleri grubudur. Dalak lenfomas\u0131, genellikle dalak \u00fczerinde birincil etki olarak ortaya \u00e7\u0131kmas\u0131 ve \u00e7evre dokulara yerel veya yayg\u0131n yay\u0131lma g\u00f6stermesi nedeniyle benzersizdir.<\/p>\n\n\n\n

Dalak Lenfomas\u0131 T\u00fcrleri<\/h3>\n\n\n\n

\u201cDalak lenfomas\u0131\u201d terimi genellikle dalakla ilgili herhangi bir lenfoma i\u00e7in kullan\u0131lsa da, yer alan lenfoma h\u00fccrelerinin t\u00fcr\u00fcne g\u00f6re daha fazla s\u0131n\u0131fland\u0131r\u0131labilir. Bunlar \u015funlar\u0131 i\u00e7erir:<\/p>\n\n\n\n

    \n
  1. Dalak Marjinal B\u00f6lge Lenfomas\u0131 (SMZL):<\/strong>
    Dalak lenfomas\u0131n\u0131n en yayg\u0131n alt t\u00fcr\u00fc olan SMZL, genellikle dalak kenar b\u00f6lgesinden kaynaklan\u0131r. Bu t\u00fcr lenfoma, yava\u015f ilerlemesi ve nispeten indolent klinik seyri ile karakterizedir.<\/li>\n\n\n\n
  2. Diff\u00fcz B\u00fcy\u00fck B-H\u00fccreli Lenfoma (DLBCL):<\/strong>
    Dalak dahil daha yayg\u0131n bir hastal\u0131k s\u00fcrecinin par\u00e7as\u0131 olabilen daha agresif bir lenfoma t\u00fcr\u00fcd\u00fcr. DLBCL, h\u0131zla b\u00fcy\u00fcy\u00fcp yay\u0131labilen bir B-h\u00fccreli lenfoma alt t\u00fcr\u00fcd\u00fcr.<\/li>\n\n\n\n
  3. K\u0131ll\u0131 H\u00fccre L\u00f6semisi (HCL):<\/strong>
    Teknik olarak lenfoma olarak s\u0131n\u0131fland\u0131r\u0131lmasa da, HCL genellikle dalakla ili\u015fkilidir ve dalak lenfomas\u0131 ile dalak b\u00fcy\u00fcmesi (dalak b\u00fcy\u00fcmesi) gibi bir\u00e7ok \u00f6zelli\u011fi payla\u015f\u0131r.<\/li>\n\n\n\n
  4. Dalak T-h\u00fccreli Lenfomas\u0131:<\/strong>
    Bu nadir alt t\u00fcr, T-h\u00fccrelerinden kaynaklan\u0131r ve daha agresif olma ve tedavi edilmesi daha zor olma e\u011filimindedir.<\/li>\n<\/ol>\n\n\n\n

    Dalak Lenfomas\u0131n\u0131n Belirtileri<\/h3>\n\n\n\n

    Dalak lenfomas\u0131n\u0131n belirtileri, hastal\u0131\u011f\u0131n evresine ve di\u011fer organlara yay\u0131l\u0131p yay\u0131lmad\u0131\u011f\u0131na ba\u011fl\u0131 olarak b\u00fcy\u00fck \u00f6l\u00e7\u00fcde de\u011fi\u015febilir. Yayg\u0131n belirtiler \u015funlard\u0131r:<\/p>\n\n\n\n

      \n
    • Dalak B\u00fcy\u00fcmesi:<\/strong> Dalak lenfomas\u0131n\u0131n en belirgin \u00f6zelli\u011fi, b\u00fcy\u00fcm\u00fc\u015f bir dalakt\u0131r. Bu, kar\u0131n b\u00f6lgesinde rahats\u0131zl\u0131k, a\u011fr\u0131 veya dolgunluk hissi yaratabilir.<\/li>\n\n\n\n
    • Yorgunluk ve Zay\u0131fl\u0131k:<\/strong> Bir\u00e7ok kanser t\u00fcr\u00fcnde oldu\u011fu gibi, yorgunluk yayg\u0131n bir belirtidir. Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi kanserli h\u00fccrelerle m\u00fccadele ederken v\u00fccudun enerji seviyeleri t\u00fckenebilir.<\/li>\n\n\n\n
    • Kilo Kayb\u0131:<\/strong> A\u00e7\u0131klanamayan kilo kayb\u0131, \u00f6zellikle hastal\u0131k ilerledik\u00e7e lenfoma vakalar\u0131nda s\u0131k\u00e7a g\u00f6r\u00fcl\u00fcr.<\/li>\n\n\n\n
    • Ate\u015f ve Gece Terlemeleri:<\/strong> Bunlar, lenfoma ile birlikte g\u00f6r\u00fclebilen sistemik belirtilerdir ve hastal\u0131\u011f\u0131n daha ileri bir evresini i\u015faret eder.<\/li>\n\n\n\n
    • Anemi veya D\u00fc\u015f\u00fck Kan Say\u0131mlar\u0131:<\/strong> Kemik ili\u011fi \u00fczerindeki etkisi nedeniyle, dalak lenfomas\u0131 anemiye yol a\u00e7abilir ve bu da solgunluk, ba\u015f d\u00f6nmesi ve nefes darl\u0131\u011f\u0131 gibi belirtilere neden olabilir.<\/li>\n\n\n\n
    • Kar\u0131n Rahats\u0131zl\u0131\u011f\u0131:<\/strong> Dalak b\u00fcy\u00fcmesi, sol \u00fcst kar\u0131n b\u00f6lgesinde dolgunluk, \u015fi\u015fkinlik veya rahats\u0131zl\u0131k hissine neden olabilir ve bu durum alt kaburgalarda a\u011fr\u0131ya bile yol a\u00e7abilir.<\/li>\n<\/ul>\n\n\n\n

      Dalak Lenfomas\u0131n\u0131n Te\u015fhisi<\/h3>\n\n\n\n

      Dalak lenfomas\u0131n\u0131n te\u015fhisi, semptomlar\u0131n \u00e7e\u015fitlili\u011fi ve di\u011fer hastal\u0131klar\u0131 taklit etme olas\u0131l\u0131\u011f\u0131 nedeniyle zorlay\u0131c\u0131 olabilir. Dalak lenfomas\u0131n\u0131n varl\u0131\u011f\u0131n\u0131 do\u011frulamak i\u00e7in birka\u00e7 tan\u0131 arac\u0131 ve prosed\u00fcr\u00fc kullan\u0131lmaktad\u0131r:<\/p>\n\n\n\n

        \n
      1. Fiziksel Muayene:<\/strong>
        Doktor, rutin bir muayene s\u0131ras\u0131nda dalak b\u00fcy\u00fcmesini fark edebilir. Kar\u0131n muayenesi genellikle durumu te\u015fhis etmenin ilk ad\u0131m\u0131d\u0131r.<\/li>\n\n\n\n
      2. Kan Testleri:<\/strong>
        Tam kan say\u0131m\u0131 (CBC) ve karaci\u011fer fonksiyon testleri, anemi, d\u00fc\u015f\u00fck trombosit say\u0131s\u0131 veya y\u00fcksek beyaz kan h\u00fccresi say\u0131s\u0131 gibi anormallikleri ortaya \u00e7\u0131karabilir; bu da lenfoma olabilece\u011fini d\u00fc\u015f\u00fcnd\u00fcrebilir. Laktat dehidrogenaz (LDH) gibi spesifik belirte\u00e7ler de y\u00fckselmi\u015f olabilir.<\/li>\n\n\n\n
      3. G\u00f6r\u00fcnt\u00fcleme \u00c7al\u0131\u015fmalar\u0131:<\/strong>
        Ultrason, BT taramalar\u0131 veya MRI gibi g\u00f6r\u00fcnt\u00fcleme teknikleri, dalak boyutunu g\u00f6rselle\u015ftirmeye ve di\u011fer organlar\u0131n etkilenip etkilenmedi\u011fini veya lenfadenopatiyi (\u015fi\u015fmi\u015f lenf d\u00fc\u011f\u00fcmleri) tespit etmeye yard\u0131mc\u0131 olabilir.<\/li>\n\n\n\n
      4. Biyopsi:<\/strong>
        Dalak lenfomas\u0131n\u0131n kesin te\u015fhisi, dalak veya di\u011fer etkilenen dokulardan biyopsi almay\u0131 gerektirir. Baz\u0131 durumlarda, kemik ili\u011fi etkileniyorsa kemik ili\u011fi biyopsisi de yap\u0131labilir.<\/li>\n\n\n\n
      5. Ak\u0131\u015f Sitometrisi ve \u0130mm\u00fcnohistokimya:<\/strong>
        Bu teknikler, yer alan spesifik lenfosit t\u00fcrlerini analiz etmek ve lenfoman\u0131n h\u00fccre belirte\u00e7lerini tan\u0131mlamak i\u00e7in kullan\u0131l\u0131r; bu da kesin alt tipin belirlenmesine yard\u0131mc\u0131 olur.<\/li>\n<\/ol>\n\n\n\n

        Dalak Lenfomas\u0131 i\u00e7in Tedavi Se\u00e7enekleri<\/h3>\n\n\n\n

        Dalak lenfomas\u0131 i\u00e7in tedavi, lenfoman\u0131n alt tipi, hastal\u0131\u011f\u0131n evresi, hastan\u0131n ya\u015f\u0131 ve genel sa\u011fl\u0131\u011f\u0131 gibi birka\u00e7 fakt\u00f6re ba\u011fl\u0131d\u0131r. Yayg\u0131n tedavi yakla\u015f\u0131mlar\u0131 \u015funlard\u0131r:<\/p>\n\n\n\n

          \n
        1. Kemoterapi:<\/strong>
          Dalak lenfomas\u0131 i\u00e7in temel tedavi, v\u00fccuttaki lenfoma h\u00fccrelerini \u00f6ld\u00fcrmeyi ama\u00e7layan kemoterapidir. Rejimler, hem lenfoma hem de v\u00fccudun di\u011fer b\u00f6lgelerine yay\u0131lm\u0131\u015f olabilecek h\u00fccreleri hedefleyen kombinasyon kemoterapisi (\u00f6rne\u011fin, CHOP veya CVP) i\u00e7erebilir.<\/li>\n\n\n\n
        2. Radyasyon Tedavisi:<\/strong>
          Lokalize hastal\u0131k i\u00e7in, dalak veya di\u011fer etkilenen alanlar\u0131 hedeflemek amac\u0131yla radyoterapi kullan\u0131labilir. Ancak, radyoterapi genellikle yaln\u0131zca kemoterapinin yeterli olmad\u0131\u011f\u0131 durumlar i\u00e7in ayr\u0131lm\u0131\u015ft\u0131r.<\/li>\n\n\n\n
        3. \u0130mm\u00fcnoterap\u0131:<\/strong>
          Monoklonal antikorlar (\u00f6rne\u011fin, rituksimab) gibi imm\u00fcnoterapiler, lenfoma h\u00fccrelerindeki spesifik proteinleri hedef alarak ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kanserle sava\u015fma yetene\u011fini art\u0131r\u0131r.<\/li>\n\n\n\n
        4. Dalak Ameliyat\u0131:<\/strong>
          Dalak (splenektomi) cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131 baz\u0131 durumlarda, \u00f6zellikle dalak \u015fiddetli a\u011fr\u0131 veya di\u011fer komplikasyonlara neden oluyorsa d\u00fc\u015f\u00fcn\u00fclebilir. Ancak, splenektomi lenfoma i\u00e7in k\u00fcratif bir tedavi de\u011fildir ve genellikle di\u011fer tedavilerle birlikte kullan\u0131l\u0131r.<\/li>\n\n\n\n
        5. Hedefe Y\u00f6nelik Tedavi:<\/strong>
          Hedefe y\u00f6nelik tedavilerdeki son geli\u015fmeler, daha hassas tedavi se\u00e7enekleri sunmu\u015ftur. \u00d6zellikle lenfoma h\u00fccrelerinin genetik mutasyonlar\u0131n\u0131 veya h\u00fccresel yollar\u0131n\u0131 hedefleyen ila\u00e7lar, dalak lenfomas\u0131 tedavisi i\u00e7in ara\u015ft\u0131r\u0131lmaktad\u0131r.<\/li>\n\n\n\n
        6. K\u00f6k H\u00fccre veya Kemik \u0130li\u011fi Nakli:<\/strong>
          \u0130leri veya tedaviye diren\u00e7li dalak lenfomas\u0131 olan hastalar i\u00e7in k\u00f6k h\u00fccre nakli bir se\u00e7enek olabilir. Bu tedavi, agresif kemoterapiden sonra hasar g\u00f6rm\u00fc\u015f kemik ili\u011fini sa\u011fl\u0131kl\u0131 k\u00f6k h\u00fccrelerle de\u011fi\u015ftirmeyi ama\u00e7lar.<\/li>\n<\/ol>\n\n\n\n

          Prognoz ve G\u00f6r\u00fcn\u00fcm<\/h3>\n\n\n\n

          Dalak lenfomas\u0131 olan hastalar i\u00e7in prognoz, hastal\u0131\u011f\u0131n t\u00fcr\u00fcne ve evresine ba\u011fl\u0131 olarak geni\u015f bir yelpazede de\u011fi\u015fiklik g\u00f6stermektedir. Genel olarak, dalak lenfomas\u0131, \u00f6zellikle Dalak Marjinal B\u00f6lge Lenfomas\u0131 (SMZL) gibi yava\u015f seyirli alt t\u00fcrler s\u00f6z konusu oldu\u011funda, di\u011fer lenfoma t\u00fcrlerine k\u0131yasla daha olumlu bir prognoza sahip olma e\u011filimindedir. Ancak, Diff\u00fcz B\u00fcy\u00fck B-H\u00fccreli Lenfoma (DLBCL) gibi daha agresif formlar yo\u011fun tedavi gerektirebilir ve daha az olumlu bir g\u00f6r\u00fcn\u00fcm sergileyebilir.<\/p>\n\n\n\n

          Erken tan\u0131 ve \u00f6zel tedavi planlar\u0131, hayatta kalma oranlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rmaktad\u0131r. Hedefe y\u00f6nelik tedaviler ve imm\u00fcnoterapilerdeki ilerlemelerle, dalak lenfomas\u0131 olan hastalar art\u0131k hastal\u0131\u011f\u0131 y\u00f6netme ve tatmin edici bir ya\u015fam s\u00fcrme konusunda daha iyi \u015fansa sahiptir.<\/p>\n\n\n\n

          Sonu\u00e7<\/h3>\n\n\n\n

          Dalak lenfomas\u0131, nadir olmas\u0131na ra\u011fmen, sonu\u00e7lar\u0131 iyile\u015ftirmek i\u00e7in zaman\u0131nda tan\u0131 ve uygun tedavi gerektiren \u00f6nemli bir hastal\u0131kt\u0131r. Ara\u015ft\u0131rmalar ilerledik\u00e7e, daha yeni tedaviler ve daha hassas tan\u0131 y\u00f6ntemleri bu durumun y\u00f6netimini geli\u015ftirmektedir. Belirtilerini, tedavi se\u00e7eneklerini ve potansiyel zorluklar\u0131 anlamak, dalak lenfomas\u0131n\u0131n karma\u015f\u0131kl\u0131klar\u0131n\u0131 a\u015fmak ve etkilenenlerin ya\u015fam kalitesini art\u0131rmak i\u00e7in hem hastalar hem de sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131 i\u00e7in kritik \u00f6neme sahiptir.<\/p>\n\n\n\n

          <\/p>","protected":false},"excerpt":{"rendered":"

          Splenic lymphoma is a rare and often challenging disease that affects the spleen, an essential organ in the body\u2019s immune system. While lymphoma is generally categorized into Hodgkin and non-Hodgkin types, splenic lymphoma usually falls under the latter. The condition is characterized by the uncontrolled growth of abnormal lymphocytes (a type of white blood cell) […]<\/p>\n","protected":false},"author":1,"featured_media":10928,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"1080","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[4],"tags":[1325,882,6125,6128,1157,6129,6127,6126,6130],"class_list":["post-10927","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dog-cancer-and-tumor","tag-cancer-diagnosis","tag-cancer-treatment","tag-hematologic-malignancies","tag-lymphatic-system-cancer","tag-lymphoma","tag-oncology","tag-rare-cancers","tag-spleen-cancer","tag-splenic-lymphoma"],"jetpack_featured_media_url":"https:\/\/www.tcm-vet.com\/wp-content\/uploads\/2024\/12\/DALL\u00b7E-2024-12-26-11.34.14-A-playful-dog-running-in-a-lush-green-backyard.-The-dog-is-medium-sized-with-a-golden-coat-and-its-ears-are-perked-up-as-it-sprints-happily-across-t.webp","jetpack-related-posts":[{"id":24947,"url":"https:\/\/www.tcm-vet.com\/tr\/samoyed-cancer-risks-essential-early-tumor-signs-to-know-4\/","url_meta":{"origin":10927,"position":0},"title":"Samoyed Kanser Riskleri: Bilinmesi Gereken Temel Erken T\u00fcm\u00f6r Belirtileri","author":"TCMVET","date":"Aral\u0131k 15, 2025","format":false,"excerpt":"Samoyed kanser riskleri, Samoyed'lerde erken t\u00fcm\u00f6r belirtileri, bu \u0131rkta yayg\u0131n kanserler - sevgi dolu sahipler i\u00e7in a\u00e7\u0131kland\u0131 - ince de\u011fi\u015fiklikleri daha erken fark edin. Bug\u00fcn daha fazlas\u0131n\u0131 \u00f6\u011frenin.","rel":"","context":""Dog Cancer & Tumors" i\u00e7inde","block_context":{"text":"Dog Cancer & Tumors","link":"https:\/\/www.tcm-vet.com\/tr\/category\/dog-cancer-and-tumor\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":25647,"url":"https:\/\/www.tcm-vet.com\/tr\/maltese-cancer-risks-early-tumor-signs-and-best-prevention\/","url_meta":{"origin":10927,"position":1},"title":"Maltese Kanser Riskleri: Erken T\u00fcm\u00f6r Belirtileri ve En \u0130yi \u00d6nleme","author":"TCMVET","date":"Aral\u0131k 18, 2025","format":false,"excerpt":"Maltese kanser riskleri, Maltese k\u00f6peklerde erken t\u00fcm\u00f6r belirtileri, bu \u0131rk\u0131n yayg\u0131n kanserleri\u2014ince de\u011fi\u015fiklikleri daha erken fark edin ve daha haz\u0131rl\u0131kl\u0131 hissedin. Daha fazla bilgi edinin.","rel":"","context":""Dog Cancer & Tumors" i\u00e7inde","block_context":{"text":"Dog Cancer & Tumors","link":"https:\/\/www.tcm-vet.com\/tr\/category\/dog-cancer-and-tumor\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":24912,"url":"https:\/\/www.tcm-vet.com\/tr\/common-labrador-cancer-risks-early-tumor-signs-to-avoid\/","url_meta":{"origin":10927,"position":2},"title":"Yayg\u0131n Labrador Kanser Riskleri ve Ka\u00e7\u0131n\u0131lmas\u0131 Gereken Erken T\u00fcm\u00f6r Belirtileri","author":"TCMVET","date":"Aral\u0131k 12, 2025","format":false,"excerpt":"Labrador Retriever kanser riskleri, Labradolarda erken t\u00fcm\u00f6r belirtileri, bu \u0131rkta yayg\u0131n kanserler, ilgili sahipler i\u00e7in a\u00e7\u0131klanm\u0131\u015ft\u0131r\u2014neleri g\u00f6zlemlemeniz gerekti\u011fini g\u00f6r\u00fcn ve daha fazla bilgi edinin.","rel":"","context":""Dog Cancer & Tumors" i\u00e7inde","block_context":{"text":"Dog Cancer & Tumors","link":"https:\/\/www.tcm-vet.com\/tr\/category\/dog-cancer-and-tumor\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":24911,"url":"https:\/\/www.tcm-vet.com\/tr\/golden-retriever-cancer-risks-early-tumor-signs-and-best-protection\/","url_meta":{"origin":10927,"position":3},"title":"Golden Retriever Kanser Riskleri: Erken T\u00fcm\u00f6r Belirtileri ve En \u0130yi Koruma","author":"TCMVET","date":"Aral\u0131k 12, 2025","format":false,"excerpt":"Golden Retriever kanser riskleri, Golden Retriever'larda erken t\u00fcm\u00f6r belirtileri, bu \u0131rk\u0131n yayg\u0131n kanserleri\u2014ince de\u011fi\u015fiklikleri fark edin, yavrunuzu destekleyin ve bug\u00fcn daha fazla bilgi edinin.","rel":"","context":""Dog Cancer & Tumors" i\u00e7inde","block_context":{"text":"Dog Cancer & Tumors","link":"https:\/\/www.tcm-vet.com\/tr\/category\/dog-cancer-and-tumor\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":24677,"url":"https:\/\/www.tcm-vet.com\/tr\/mastiff-cancer-risks-essential-early-symptoms-to-detect\/","url_meta":{"origin":10927,"position":4},"title":"Mastiff Kanser Riskleri: Tespit \u0130\u00e7in Temel Erken Belirtiler","author":"TCMVET","date":"Aral\u0131k 11, 2025","format":false,"excerpt":"Mastiff kanser riskleri, Mastiflerde erken t\u00fcm\u00f6r belirtileri, bu \u0131rktaki yayg\u0131n kanserler - ince de\u011fi\u015fiklikleri tespit edin, nazik devinizi destekleyin ve bug\u00fcn daha fazla bilgi edinin.","rel":"","context":""Dog Cancer & Tumors" i\u00e7inde","block_context":{"text":"Dog Cancer & Tumors","link":"https:\/\/www.tcm-vet.com\/tr\/category\/dog-cancer-and-tumor\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":25254,"url":"https:\/\/www.tcm-vet.com\/tr\/common-cancers-in-this-breed-westie-cancer-risks-and-early-signs\/","url_meta":{"origin":10927,"position":5},"title":"Bu \u0131rkta yayg\u0131n kanserler: Westie kanser riskleri ve erken belirtiler","author":"TCMVET","date":"Aral\u0131k 16, 2025","format":false,"excerpt":"Westie kanser riskleri, Westie'lerde erken t\u00fcm\u00f6r belirtileri, bu \u0131rkta yayg\u0131n kanserler\u2014de\u011fi\u015fiklikleri daha erken fark edin, ya\u015fl\u0131 yavrunuzun konforunu destekleyin ve bug\u00fcn daha fazla bilgi edinin.","rel":"","context":""Dog Cancer & Tumors" i\u00e7inde","block_context":{"text":"Dog Cancer & Tumors","link":"https:\/\/www.tcm-vet.com\/tr\/category\/dog-cancer-and-tumor\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/posts\/10927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/comments?post=10927"}],"version-history":[{"count":0,"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/posts\/10927\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/media\/10928"}],"wp:attachment":[{"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/media?parent=10927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/categories?post=10927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tcm-vet.com\/tr\/wp-json\/wp\/v2\/tags?post=10927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}